| Ticker Details |
|
Zura Bio Limited
|
| IPO Date: |
March 1, 2023 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$560.6M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.24 | 4.92%
|
| Avg Daily Range (30 D): |
$0.15 | 2.67%
|
| Avg Daily Range (90 D): |
$0.17 | 3.56%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.52M |
| Avg Daily Volume (30 D): |
.67M |
| Avg Daily Volume (90 D): |
.79M |
| Trade Size |
| Avg Trade Size (Sh.): |
125 |
| Avg Trade Size (Sh.) (30 D): |
79 |
| Avg Trade Size (Sh.) (90 D): |
90 |
| Institutional Trades |
| Total Institutional Trades: |
89 |
| Avg Institutional Trade: |
$1.76M |
| Avg Institutional Trade (30 D): |
$.64M |
| Avg Institutional Trade (90 D): |
$1.97M |
| Avg Institutional Trade Volume: |
.44M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.17M |
| Avg Closing Trade (30 D): |
$.72M |
| Avg Closing Trade (90 D): |
$5.46M |
| Avg Closing Volume: |
921.97K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-1.13
|
$-.21
|
$-.22
|
|
Diluted EPS
|
$-1.13
|
$-.21
|
$-.22
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-35.27M
|
$-26.3M
|
$-24.22M
|
|
Operating Income / Loss
|
$-92.75M
|
$-29.32M
|
$-25.5M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-66.97M
|
$-116.09M
|
$116.19M
|
|
PE Ratio
|
|
|
|
|
|
|